Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Clinical Trial to Compare Adverse Birth Outcomes in Pregnant Women Receiving Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus Quadrivalent Inactivated Influenza Vaccine (IIV4)
Conditions
Interventions
Quadrivalent Recombinant Influenza Vaccine
Quadrivalent Inactivated Influenza Vaccine
Locations
3
United States
Boston Medical Center
Boston, Massachusetts, United States
Duke University Medical Center
Durham, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
September 5, 2019
Primary Completion Date
September 29, 2021
Completion Date
September 29, 2021
Last Updated
January 11, 2023
NCT07256522
NCT04592640
NCT04854278
NCT07253896
NCT06244537
NCT05583006
Lead Sponsor
Duke University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions